Get the Stockscreener App
22.30
1.09%
0.24
Surgery Partners Inc stock is traded at $22.30, with a volume of 46,833.
It is up +1.09% in the last 24 hours and up +10.40% over the past month.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
See More
Previous Close:
$22.06
Open:
$22.3
24h Volume:
46,833
Relative Volume:
0.03
Market Cap:
$2.86B
Revenue:
$2.89B
Net Income/Loss:
$-33.80M
P/E Ratio:
-82.59
EPS:
-0.27
Net Cash Flow:
$204.10M
1W Performance:
-1.50%
1M Performance:
+10.40%
6M Performance:
+8.20%
1Y Performance:
-21.31%
1-Day Range:
$21.99
$22.40
1-Week Range:
$21.97
$22.88
52-Week Range:
$18.87
$33.97
Surgery Partners Inc Stock (SGRY) Company Profile
Name
Surgery Partners Inc
Sector
Industry
Phone
615-234-5900
Address
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
22.30 | 2.80B | 2.89B | -33.80M | 204.10M | -0.27 |
|
HCA
Hca Healthcare Inc
|
354.27 | 89.45B | 71.59B | 5.78B | 4.95B | 22.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
27.16 | 15.77B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
THC
Tenet Healthcare Corp
|
159.62 | 16.05B | 20.52B | 1.46B | 1.41B | 15.12 |
|
DVA
Davita Inc
|
151.07 | 10.62B | 12.82B | 936.34M | 1.47B | 10.74 |
|
EHC
Encompass Health Corp
|
108.00 | 10.81B | 5.51B | 494.70M | 386.40M | 4.84 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-16-24 | Initiated | BofA Securities | Buy |
| Oct-14-24 | Initiated | UBS | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-28-24 | Initiated | Macquarie | Outperform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Nov-14-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Jun-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| May-12-23 | Initiated | Mizuho | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-23-22 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-15-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Nov-30-21 | Initiated | Barclays | Overweight |
| Nov-29-21 | Upgrade | Stifel | Hold → Buy |
| Nov-01-21 | Initiated | JP Morgan | Neutral |
| Oct-18-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Jun-23-21 | Resumed | Stifel | Hold |
| Sep-17-20 | Reiterated | The Benchmark Company | Buy |
| Apr-27-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-03-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Jan-14-20 | Reiterated | The Benchmark Company | Buy |
| Nov-16-18 | Initiated | UBS | Neutral |
| Sep-18-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-28-18 | Upgrade | Stifel | Sell → Hold |
| Jan-30-18 | Reiterated | The Benchmark Company | Buy |
| Nov-01-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-09-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Aug-09-17 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Aug-09-17 | Downgrade | Stifel | Hold → Sell |
| Apr-24-17 | Reiterated | Stifel | Hold |
| Mar-10-17 | Downgrade | Stifel | Buy → Hold |
| Jan-31-17 | Initiated | The Benchmark Company | Buy |
| Jun-10-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Mar-14-16 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-15 | Initiated | Stifel | Buy |
| Oct-26-15 | Initiated | RBC Capital Mkts | Outperform |
| Oct-26-15 | Initiated | Raymond James | Strong Buy |
View All
Surgery Partners Inc Stock (SGRY) Latest News
Is Surgery Partners Inc. a good long term investmentSuperior portfolio returns - Autocar Professional
Surgery Partners Inc. Stock Analysis and ForecastSuperior risk-adjusted returns - jammulinksnews.com
What drives Surgery Partners Inc. stock priceExponentially increasing returns - jammulinksnews.com
Surgery Partners (SGRY): Buy, Sell, or Hold Post Q1 Earnings? - FinancialContent
What analysts say about Surgery Partners Inc. stockOutstanding stock performance - Autocar Professional
Long Term Trading Analysis for (SGRY) - news.stocktradersdaily.com
Surgery Partners, Inc. Announces Second Quarter 2025 Earnings Re - GuruFocus
Surgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call Details - The Manila Times
Surgery Partners Sets Q2 Earnings Date: Key Financial Updates Coming August 5 - Stock Titan
Surgery Partners Stock Rises on Positive Analyst OutlookNews and Statistics - IndexBox
Why Surgery Partners (SGRY) Stock Is Trading Up Today - Yahoo Finance
Surgery Partners stock rises as CMS proposes favorable ASC rule changes - Investing.com Canada
Surgery Partners, Inc. (SGRY): A Bull Case Theory - Insider Monkey
1 Healthcare Stock to Keep an Eye On and 2 to Be Wary Of - Yahoo Finance
Surgery Partners stock rating reiterated by Cantor Fitzgerald at Overweight - Investing.com
(SGRY) Technical Data - news.stocktradersdaily.com
U.S. Ambulatory Surgery Center Market Growth in Future Scope - openPR.com
Surgery Partners to Acquire National Surgical Healthcare from Irving Place Capital - Bain Capital
Surgery Partners stock holds Buy rating at UBS on rejected Bain offer - Investing.com Canada
Surgery Partners stock hits 52-week low at 19.49 USD - Investing.com
Surgery Partners: The Plunge Doesn't Justify An Upgrade (NASDAQ:SGRY) - Seeking Alpha
Ascension Buying AmSurg in Response to Outpatient Trend - Healthcare Innovation
U.S. Ambulatory Surgery Center Market Generated - openPR.com
UBS reiterates buy rating on Surgery Partners stock amid takeover rejection - Investing.com
Surgery Partners’ SWOT analysis: stock outlook amid pricing pressures By Investing.com - Investing.com UK
Surgery Partners ends acquisition talks with Bain Capital By Investing.com - Investing.com India
Surgery Partners’ SWOT analysis: stock outlook amid pricing pressures - Investing.com
Surgery Partners rejects Bain Capital's takeover proposal - MSN
Surgery Partners Rejects $3.3B Bain Offer - USA Herald
Surgery Partners Ends Buyout Talks with Bain Capital, Shares Slide - GuruFocus
Surgery Partners Rejects $3.3B Bain Offer, Eyes Public Growth - Law360
Surgery Partners rejects Bain Capital's take-private offer - Reuters
Surgery Partners rejects Bain Capital's acquisition offer, opts to remain public - The Business Journals
RSI Alert: Surgery Partners (SGRY) Now Oversold - Nasdaq
Surgery Partners falls after it rejects Bain Capital's take-private offer - TradingView
Surgery Partners’ Stock Dips Amid Expert Analysis of Latest Financials - timothysykes.com
Surgery Partners Stock Slumps 13% After Company Rejects Bain Capital’s Take-Private Proposal By Stocktwits - Investing.com India
Bain Capital Private Equity, LP cancelled the acquisition of remaining 60.7% stake in Surgery Partners, Inc.. - MarketScreener
Surgery Partners rejects Bain Capital’s take-private offer - 1470 & 100.3 WMBD
Surgery Partners Rejects Bain Capital's Private Buyout Offer, Will Remain Independent - Benzinga
Surgery Partners rejects Bain Capital's takeover proposal (SGRY) - Seeking Alpha
Surgery Partners stock falls after concluding discussions with Bain Capital - Investing.com
Surgery Partners ends acquisition talks with Bain Capital - Investing.com
Surgery Partners Decides to Remain Independent - TipRanks
Surgery Partners (SGRY) Confirms 2025 Financial Projections | SG - GuruFocus
Surgery Partners, Bain Capital conclude discussions - TipRanks
SURGERY PARTNERS, INC. and Bain Capital Conclude Discussions - The Manila Times
Surgery Partners Inc Stock (SGRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Surgery Partners Inc Stock (SGRY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Burkhalter Danielle | Chief Human Resources Officer |
Mar 14 '25 |
Sale |
23.78 |
74 |
1,760 |
44,839 |
| Webb William Trenton | American Group President |
Mar 14 '25 |
Sale |
23.70 |
138 |
3,271 |
74,521 |
0.10%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):